Search for: "United States v. Article of Drug" Results 2101 - 2120 of 2,497
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Apr 2015, 10:53 am
  It also throws an important light on the issue of the structures for constraining the use of police power in states that may be useful, especially perhaps for those confronting similar issues in the United States (see, e.g., here and here). [read post]
5 Feb 2021, 2:24 pm by admin
See also James Beck & Mark Herrmann, “No Injury Cheat Sheet,” Drug & Device Law Blog (July 3, 2008). [8]  Metro-North Commuter R.R. v. [read post]
22 Jul 2013, 8:05 am by The Charge
  Considered a "landmark case", Epperson v. [read post]
2 Nov 2021, 8:26 pm by David Kopel
The rest of the United States has two types of policies. [read post]
26 Oct 2023, 8:27 am by Amy Howe
Bruen, in which the court struck down New York’s handgun-licensing scheme, the justices will hear argument in another major gun-rights case: United States v. [read post]
10 Sep 2012, 4:33 am
  Forfeiture by wrongdoing in a principle in the common law that was first recognized by the United States Supreme Court in Reynolds v. [read post]
23 Jun 2022, 9:03 pm by Dan Flynn
The federal Western District Court for Texas calls the United States v. [read post]
28 Mar 2018, 9:33 am by Ad Law Defense
  Plaintiffs also argue that the listing and warning requirement conflict with, and are preempted by Federal legislation,notably the United States Food, Drug, and Cosmetic Act (FDCA) and Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). [read post]
1 Apr 2007, 9:00 pm
 On March 19, 2007, the United States Supreme Court heard this "Bong Hits 4 Jesus" case, formally known as  Morse v. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]